1. Synthesis and pharmacological evaluation of pyrazolo[4,3-c]quinolinones as high affinity GABA A -R ligands and potential anxiolytics.
- Author
-
López Rivilli MJ, Turina AV, Bignante EA, Molina VH, Perillo MA, Briñon MC, and Moyano EL
- Subjects
- Animals, Anti-Anxiety Agents chemical synthesis, Anti-Anxiety Agents chemistry, Dose-Response Relationship, Drug, Ligands, Male, Molecular Structure, Quinolones chemical synthesis, Quinolones chemistry, Rats, Rats, Wistar, Structure-Activity Relationship, Anti-Anxiety Agents pharmacology, Anxiety drug therapy, Behavior, Animal drug effects, Maze Learning drug effects, Quinolones pharmacology, Receptors, GABA-A metabolism
- Abstract
The synthesis, in vitro ligand binding study and in vivo Elevated Plus Maze test (EPM) of a series of pyrazolo[4,3-c]quinolin-3-ones (PQs) are reported. Multistep synthesis of PQs started from anilines and diethyl 2-(ethoxymethylene)malonate to give the quinolin-4-one nucleus, via the Gould-Jacobs reaction. These quinolinones were transformed to 4-chloroquinolines, which react with aryl-hydrazines affording the final compounds. PQs exhibited different potency in displacing specific [
3 H]Flunitrazepam binding from the benzodiazepine binding site at the γ-aminobutyric acid receptor (GABAA -R) depending on the substitution of the pyrazoloquinolone nucleus. PCA helped determine how different substituents contributed to the differential behavior of the PQs studied. Compounds with high affinity for the GABAA -R were tested regarding their anxiolytic properties in Wistar adult male rats using the Elevated Plus Maze (EPM). Thus, PQs with a p-methoxy phenyl group at N-1 (7b-ii and 7c-ii) displayed a remarkable anxiolytic activity at low doses (0.5-1.0 mg/kg). Meanwhile, PQs featuring an unsubstituted phenyl (7b-i) or p-fluoro phenyl group (7b-iii) at the N-1 showed anxiogenic effects in the EPM test., (Copyright © 2018 Elsevier Ltd. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF